TGF‐β1 targets Smad, p38 MAPK, and PI 3K/Akt signaling pathways to induce PFKFB 3 gene expression and glycolysis in glioblastoma cells A Rodríguez‐García, P Samsó, P Fontova, H Simon‐Molas, A Manzano, ... The FEBS Journal 284 (20), 3437-3454, 2017 | 145 | 2017 |
Online haemodiafiltration improves inflammatory state in dialysis patients: a longitudinal study I Rama, I Llaudo, P Fontova, G Cerezo, C Soto, C Javierre, M Hueso, ... PLoS One 11 (10), e0164969, 2016 | 28 | 2016 |
PI3K–Akt signaling controls PFKFB3 expression during human T-lymphocyte activation H Simon-Molas, C Arnedo-Pac, P Fontova, A Vidal-Alabro, E Castaño, ... Molecular and Cellular Biochemistry 448, 187-197, 2018 | 26 | 2018 |
Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of … C El Haj, O Murillo, A Ribera, N Lloberas, J Gómez-Junyent, F Tubau, ... International journal of antimicrobial agents 51 (6), 854-861, 2018 | 24 | 2018 |
Donor/recipient HLA molecular mismatch scores predict primary humoral and cellular alloimmunity in kidney transplantation M Meneghini, E Crespo, M Niemann, A Torija, N Lloberas, V Pernin, ... Frontiers in immunology 11, 623276, 2021 | 21 | 2021 |
Influence of the circadian timing system on tacrolimus pharmacokinetics and pharmacodynamics after kidney transplantation P Fontova, H Colom, R Rigo-Bonnin, LN Van Merendonk, A Vidal-Alabro, ... Frontiers in Pharmacology 12, 636048, 2021 | 18 | 2021 |
The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis J Guiteras, É Ripoll, N Bolaños, L De Ramon, P Fontova, N Lloberas, ... Molecular Therapy-Nucleic Acids 24, 807-821, 2021 | 10 | 2021 |
TGF-b1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells A Rodrıguez-Garcıa, P Samsó, P Fontova, H Simon-Molas, A Manzano, ... FEBS J 284 (20), 3437-54, 2017 | 9 | 2017 |
Sustained Inhibition of Calcineurin Activity With a Melt‐Dose Once‐daily Tacrolimus Formulation in Renal Transplant Recipients P Fontova, H Colom, R Rigo‐Bonnin, O Bestard, A Vidal‐Alabró, ... Clinical Pharmacology & Therapeutics 110 (1), 238-247, 2021 | 8 | 2021 |
Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients … P Fontova, R Rigo-Bonnin, A Vidal-Alabro, G Cerezo, O Bestard, ... Clinica Chimica Acta 495, 287-293, 2019 | 7 | 2019 |
ANRIL as a genetic marker for cardiovascular events in renal transplant patients – an observational follow‐up cohort study A Arbiol‐Roca, A Padró‐Miquel, A Vidal‐Alabró, M Hueso, P Fontova, ... Transplant International 31 (9), 1018-1027, 2018 | 6 | 2018 |
Dual and opposite costimulatory targeting with a novel human fusion recombinant protein effectively prevents renal warm ischemia reperfusion injury and allograft rejection in … J Guiteras, L De Ramon, E Crespo, N Bolaños, S Barcelo-Batllori, ... International Journal of Molecular Sciences 22 (3), 1216, 2021 | 5 | 2021 |
Validation and evaluation of four sample preparation methods for the quantification of intracellular tacrolimus in peripheral blood mononuclear cells by UHPLC-MS/MS LN van Merendonk, P Fontova, R Rigo-Bonnin, H Colom, A Vidal-Alabró, ... Clinica Chimica Acta 503, 210-217, 2020 | 5 | 2020 |
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction N Lloberas, JM Grinyó, H Colom, A Vidal-Alabró, P Fontova, ... Kidney International 104 (4), 840-850, 2023 | 4 | 2023 |
A potent fluorescent transmembrane HCl transporter perturbs cellular pH and promotes cancer cell death M Fares, X Wu, DA McNaughton, AM Gilchrist, W Lewis, PA Keller, ... Organic & Biomolecular Chemistry 21 (12), 2509-2515, 2023 | 4 | 2023 |
A novel late-stage autophagy inhibitor that efficiently targets lysosomes inducing potent cytotoxic and sensitizing effects in lung cancer A Molero-Valenzuela, P Fontova, D Alonso-Carrillo, I Carreira-Barral, ... Cancers 14 (14), 3387, 2022 | 4 | 2022 |
TP53-induced glycolysis and apoptosis regulator (TIGAR) is upregulated in lymphocytes stimulated with concanavalin A H Simon-Molas, X Vallvé-Martínez, I Caldera-Quevedo, P Fontova, ... International journal of molecular sciences 22 (14), 7436, 2021 | 4 | 2021 |
Mycophenolic acid interferes the transcriptional regulation and protein trafficking of maturation surface markers in dendritic cells P Fontova, I Rama, I Llaudó, A Vidal-Alabró, G Cerezo, A Manzano, ... International Immunopharmacology 91, 107025, 2021 | 4 | 2021 |
Dual costimulatory and coinhibitory targeting with a hybrid fusion protein as an immunomodulatory therapy in lupus nephritis mice models J Guiteras, E Crespo, P Fontova, N Bolaños, M Gomà, E Castaño, ... International journal of molecular sciences 23 (15), 8411, 2022 | 3 | 2022 |
Steric hindrance, ligand ejection and associated photocytotoxic properties of ruthenium (II) polypyridyl complexes P Herrera-Ramírez, SA Berger, D Josa, D Aguilà, AB Caballero, ... JBIC Journal of Biological Inorganic Chemistry 28 (4), 403-420, 2023 | 2 | 2023 |